Immediate Impact
14 standout
Citing Papers
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
2024 Standout
Bispecific antibody drug conjugates: Making 1+1>2
2024 Standout
Works of M. Untch being referenced
58O Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Untch | 39 | 13 | 10 | 13 | 13 | 50 | |
| Roberto Di Cicilia | 31 | 17 | 22 | 7 | 14 | 61 | |
| Jing Yu | 35 | 9 | 13 | 18 | 14 | 80 | |
| Željko Soldić | 46 | 9 | 22 | 5 | 14 | 84 | |
| A. Spagnoletti | 55 | 5 | 14 | 18 | 13 | 78 | |
| Mohamed Elfagieh | 28 | 16 | 10 | 5 | 8 | 60 | |
| Vesna Glavicic | 33 | 21 | 20 | 6 | 11 | 48 | |
| Hana Zahed | 37 | 23 | 9 | 11 | 10 | 68 | |
| Paula Podolski | 21 | 11 | 11 | 15 | 11 | 61 | |
| BK Smruti | 24 | 13 | 7 | 5 | 11 | 66 | |
| Sabela Recalde | 36 | 12 | 20 | 4 | 14 | 52 |
All Works
Loading papers...